FOXP3 and mature T-cell and NK-cell non-Hodgkin lymphoma: Similarly to our findings, both groups studying nTFHLs-AI and PTCLs-NOS [16,24] reported a higher median quantity of FoxP3+ cells in nTFHL-AI patients compared to PTCL-NOS patients, but this difference was not statistically significant across the three studies.